Fabio Cappuccini

Title(s)Health Sciences Professor, Obstetrics and Gynecology
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-7971
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study. J Clin Oncol. 2022 Dec 01; 40(34):3965-3974. You B, Purdy C, Copeland LJ, Swisher EM, Bookman MA, Fleming G, Coleman R, Randall LM, Tewari KS, Monk BJ, Mannel RS, Walker JL, Cappuccini F, Cohn D, Muzaffar M, Mutch D, Wahner-Hendrickson A, Martin L, Colomban O, Burger RA. PMID: 36252167.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Platinum resistance in gynecologic malignancies: Response, disease free and overall survival are predicted by biochemical signature: A metabolomic analysis. Gynecol Oncol. 2021 10; 163(1):162-170. D'Amora P, Silva IDCG, Tewari KS, Bristow RE, Cappuccini F, Evans SS, Salzgeber MB, Addis-Bernard PJ, Palma AM, Marchioni DML, Carioca AAF, Penner KR, Alldredge J, Longoria T, Nagourney RA. PMID: 34446269.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    3. Lung cancer diagnosed on pap smear: A case report and review of the literature. Gynecol Oncol Rep. 2021 May; 36:100776. Leaf MC, Pearre D, Cappuccini F, Tewari K. PMID: 34026999; PMCID: PMC8131888.
      View in: PubMed   Mentions:
    4. Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl Oncol. 2009 Dec; 2(4):341-9. Pejovic T, Pande NT, Mori M, Mhawech-Fauceglia P, Harrington C, Mongoue-Tchokote S, Dim D, Andrews C, Beck A, Tarumi Y, Djilas J, Cappuccini F, Caballero O, Huang J, Levy S, Tsiamouri A, Cain J, Bagby GC, Strausberg RL, Simpson AJ, Odunsi KO. PMID: 19956396; PMCID: PMC2781076.
      View in: PubMed   Mentions: 16  
    5. Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res. 2006 Sep 15; 66(18):9017-25. Pejovic T, Yates JE, Liu HY, Hays LE, Akkari Y, Torimaru Y, Keeble W, Rathbun RK, Rodgers WH, Bale AE, Ameziane N, Zwaan CM, Errami A, Thuillier P, Cappuccini F, Olson SB, Cain JM, Bagby GC. PMID: 16982743.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    6. Human immunodeficiency virus testing in patients with invasive cervical carcinoma: a prospective trial of the gynecologic oncology group. Int J Gynecol Cancer. 2006 Mar-Apr; 16(2):660-3. Calkins A, Stehman FB, Bundy B, Benda JA, Mannel RS, Seago P, Cappuccini F, Alvarez RD, Monk BJ, Maiman M. PMID: 16681743.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    7. Survival outcomes in patients with recurrent ovarian cancer who were treated with chemoresistance assay-guided chemotherapy. Am J Obstet Gynecol. 2003 Nov; 189(5):1301-7. Loizzi V, Chan JK, Osann K, Cappuccini F, DiSaia PJ, Berman ML. PMID: 14634558.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    8. Chemoradiation: A new approach for the treatment of cervical cancer. Int J Gynecol Cancer. 2003 Sep-Oct; 13(5):580-6. Loizzi V, Cormio G, Loverro G, Selvaggi L, Disaia PJ, Cappuccini F. PMID: 14675339.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Primary invasive carcinoma of the vagina: treatment with interstitial brachytherapy. Cancer. 2001 Feb 15; 91(4):758-70. Tewari KS, Cappuccini F, Puthawala AA, Kuo JV, Burger RA, Monk BJ, Manetta A, Berman ML, Disaia PJ, Nisar AM. PMID: 11241244.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    10. Obstetric emergencies precipitated by malignant brain tumors. Am J Obstet Gynecol. 2000 May; 182(5):1215-21. Tewari KS, Cappuccini F, Asrat T, Flamm BL, Carpenter SE, Disaia PJ, Quilligan EJ. PMID: 10819861.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    11. Malignant germ cell tumors of the ovary. Obstet Gynecol. 2000 Jan; 95(1):128-33. Tewari K, Cappuccini F, Disaia PJ, Berman ML, Manetta A, Kohler MF. PMID: 10636515.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    12. Interstitial brachytherapy for vaginal recurrences of endometrial carcinoma. Gynecol Oncol. 1999 Sep; 74(3):416-22. Tewari K, Cappuccini F, Brewster WR, DiSaia PJ, Berman ML, Manetta A, Puthawala A, Nisar Syed AM, Kohler MF. PMID: 10479502.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    13. Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. Am J Obstet Gynecol. 1999 Jul; 181(1):91-8. Tewari K, Cappuccini F, Syed AM, Puthawala A, DiSaia PJ, Berman ML, Manetta A, Monk BJ. PMID: 10411801.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Relapse of acute lymphoblastic leukemia in pregnancy: survival following chemoirradiation and autologous transfer of interleukin-2-activated stem cells. Gynecol Oncol. 1999 Jul; 74(1):143-6. Tewari K, Cappuccini F, Rosen RB, Rosenthal J, Asrat T, Kohler MF. PMID: 10385569.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    15. Pregnancy in a Jehovah's witness with cervical cancer and anemia. Gynecol Oncol. 1998 Nov; 71(2):330-2. Tewari K, Cappuccini F, Balderston KD, Rose GS, Porto M, Berman ML. PMID: 9826482.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Aggressive clinical behavior of a rare uterine sarcoma. Gynecol Oncol. 1998 Jul; 70(1):147-51. Cappuccini F, Tewari K, Fuller PN, Pindur A, DiSaia PJ. PMID: 9698494.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer. 1998 Apr 15; 82(8):1529-34. Tewari K, Cappuccini F, Gambino A, Kohler MF, Pecorelli S, DiSaia PJ. PMID: 9554531.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    18. Advanced-stage small cell carcinoma of the ovary in pregnancy: long-term survival after surgical debulking and multiagent chemotherapy. Gynecol Oncol. 1997 Sep; 66(3):531-4. Tewari K, Brewer C, Cappuccini F, Macri C, Rogers LW, Berman ML. PMID: 9299272.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    19. Extramammary Paget's disease of the vulva: metastases to the bone marrow in the absence of an underlying adenocarcinoma--case report and literature review. Gynecol Oncol. 1997 Jul; 66(1):146-50. Cappuccini F, Tewari K, Rogers LW, DiSaia PJ. PMID: 9234936.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    20. A report of two cases of recurrent Paget's disease of the vulva in a split-thickness graft and its possible pathogenesis-labeled "retrodissemination". Gynecol Oncol. 1995 Apr; 57(1):109-12. DiSaia PJ, Dorion GE, Cappuccini F, Carpenter PM. PMID: 7705692.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice. Gynecol Oncol. 1992 Aug; 46(2):163-9. Cappuccini F, Lucci JA, Dett CA, Gatanaga M, Ininns EK, Gatanaga T, Yamamoto RS, Manetta A, DiSaia PJ, Granger GA. PMID: 1500017.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    22. Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients. Gynecol Oncol. 1992 May; 45(2):129-35. Lucci JA, Manetta A, Cappuccini F, Ininns EK, Dett CA, DiSaia P, Yamamoto RS, Berman ML, Soopikian J, Granger GA. PMID: 1592279.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    23. Growth of the endometrial adenocarcinoma cell line AN3 CA is modulated by tumor necrosis factor and its receptor is up-regulated by estrogen in vitro. Endocrinology. 1992 Apr; 130(4):1852-6. Ininns EK, Gatanaga M, Cappuccini F, Dett CA, Yamamoto RS, Granger GA, Gatanaga T. PMID: 1312427.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    24. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA- and LPS-stimulated human monocytic THP-1 cells in vitro. Cell Immunol. 1991 Nov; 138(1):1-10. Gatanaga T, Hwang CD, Gatanaga M, Cappuccini F, Yamamoto RS, Granger GA. PMID: 1655285.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    25. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer. Lymphokine Cytokine Res. 1991 Jun; 10(3):225-9. Cappuccini F, Yamamoto RS, DiSaia PJ, Grosen EA, Gatanaga M, Lucci JA, Ininns EK, Gatanaga T, Granger GA. PMID: 1653048.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    26. Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro. J Immunol. 1991 Mar 01; 146(5):1522-6. Dett CA, Gatanaga M, Ininns EK, Cappuccini F, Yamamoto RS, Granger GA, Gatanaga T. PMID: 1847164.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    27. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci U S A. 1990 Nov; 87(22):8781-4. Gatanaga T, Hwang CD, Kohr W, Cappuccini F, Lucci JA, Jeffes EW, Lentz R, Tomich J, Yamamoto RS, Granger GA. PMID: 2174164; PMCID: PMC55043.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells